Review article: The modern diagnosis and therapy of cholangiocarcinoma

Alimentary Pharmacology and Therapeutics

Volumn 23, Issue 9, 2006, Pages 1287-1296

  Malhi, H ^a   Gores, G J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CISPLATIN; EPIDERMAL GROWTH FACTOR RECEPTOR; EXATECAN; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; GEMCITABINE; HEMATOPORPHYRIN DERIVATIVE; MESYLIC ACID; REBECCAMYCIN; SORAFENIB;

ADENOCARCINOMA; ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; ANEUPLOIDY; BILE DUCT CARCINOMA; BILE DUCT OBSTRUCTION; BILIARY TRACT SURGERY; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER CYTODIAGNOSIS; CANCER DIAGNOSIS; CANCER INVASION; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CHEMOEMBOLIZATION; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DIGITAL IMAGING; DRUG TARGETING; EARLY DIAGNOSIS; ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FLUORESCENCE IN SITU HYBRIDIZATION; HIGH RISK PATIENT; HUMAN; HYPERTHERMIC THERAPY; IMAGE ANALYSIS; LIVER CELL; LIVER RESECTION; LIVER TRANSPLANTATION; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; MULTIMODALITY CANCER THERAPY; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PHOTODYNAMIC THERAPY; POSITRON EMISSION TOMOGRAPHY; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RADIODIAGNOSIS; RADIOFREQUENCY ABLATION; REVIEW; SEROLOGY; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; TUMOR BIOPSY;

BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LIVER TRANSPLANTATION; PALLIATIVE CARE; SENSITIVITY AND SPECIFICITY;

EID: 33645718033     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2006.02900.x     Document Type: Review

References (78)

1. Khan SA Davidson BR Goldin R et al. Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document Gut 2002 51 Suppl. 6 1 9
2. Weinbren K Mutum SS. Pathological aspects of cholangiocarcinoma J Pathol 1983 139 217 38
3. Lim JH Park CK. Pathology of cholangiocarcinoma Abdom Imaging 2004 29 540 7
4. Chen CY Shiesh SC Tsao HC Lin XZ. The assessment of biliary CA 125, CA 19-9 and CEA in diagnosing cholangiocarcinoma - the influence of sampling time and hepatolithiasis Hepatogastroenterology 2002 49 616 20
5. Nichols JC Gores GJ LaRusso NF Wiesner RH Nagorney DM Ritts RE. Jr. Diagnostic role of serum CA 19-9 for cholangiocarcinoma in patients with primary sclerosing cholangitis Mayo Clin Proc 1993 68 874 9
6. Patel AH Harnois DM Klee GG LaRusso NF Gores GJ. The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis Am J Gastroenterol 2000 95 204 7
7. Bloom CM Langer B Wilson SR. Role of US in the detection, characterization, and staging of cholangiocarcinoma Radiographics 1999 19 1199 218
8. Angulo P Pearce DH Johnson CD et al. Magnetic resonance cholangiography in patients with biliary disease: its role in primary sclerosing cholangitis J Hepatol 2000 33 520 7
9. Oberholzer K Lohse AW Mildenberger P et al. Diagnosis of primary sclerosing cholangitis: prospective comparison of MR cholangiography with endoscopic retrograde cholangiography Rofo 1998 169 622 6
10. Textor HJ Flacke S Pauleit D et al. Three-dimensional magnetic resonance cholangiopancreatography with respiratory triggering in the diagnosis of primary sclerosing cholangitis: comparison with endoscopic retrograde cholangiography Endoscopy 2002 34 984 90
11. Braga HJ Imam K Bluemke DA. MR imaging of intrahepatic cholangiocarcinoma: use of ferumoxides for lesion localization and extension AJR Am J Roentgenol 2001 177 111 4
12. Peterson MS Murakami T Baron RL. MR imaging patterns of gadolinium retention within liver neoplasms Abdom Imaging 1998 23 592 9
13. Lee MG Park KB Shin YM et al. Preoperative evaluation of hilar cholangiocarcinoma with contrast-enhanced three-dimensional fast imaging with steady-state precession magnetic resonance angiography: comparison with intraarterial digital subtraction angiography World J Surg 2003 27 278 83
14. Teefey SA Baron RL Rohrmann CA Shuman WP Freeny PC. Sclerosing cholangitis: CT findings Radiology 1988 169 635 9
15. Zhang Y Uchida M Abe T Nishimura H Hayabuchi N Nakashima Y. Intrahepatic peripheral cholangiocarcinoma: comparison of dynamic CT and dynamic MRI J Comput Assist Tomogr 1999 23 670 7
16. Tillich M Mischinger HJ Preisegger KH Rabl H Szolar DH. Multiphasic helical CT in diagnosis and staging of hilar cholangiocarcinoma AJR Am J Roentgenol 1998 171 651 8
17. Fritscher-Ravens A Broering DC Sriram PV et al. EUS-guided fine-needle aspiration cytodiagnosis of hilar cholangiocarcinoma: a case series Gastrointest Endosc 2000 52 534 40
18. Fritscher-Ravens A Bohuslavizki KH Broering DC et al. FDG PET in the diagnosis of hilar cholangiocarcinoma Nucl Med Commun 2001 22 1277 85
19. Harewood GC Baron TH Stadheim LM Kipp BR Sebo TJ Salomao DR. Prospective, blinded assessment of factors influencing the accuracy of biliary cytology interpretation Am J Gastroenterol 2004 99 1464 9
20. Baron TH Harewood GC Rumalla A et al. A prospective comparison of digital image analysis and routine cytology for the identification of malignancy in biliary tract strictures Clin Gastroenterol Hepatol 2004 2 214 9
21. Kipp BR Stadheim LM Halling SA et al. A comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct strictures Am J Gastroenterol 2004 99 1675 81
22. Itoi T Shinohara Y Takeda K et al. Detection of telomerase reverse transcriptase mRNA in biopsy specimens and bile for diagnosis of biliary tract cancers Int J Mol Med 2001 7 281 7
23. Aishima SI Taguchi KI Sugimachi K Shimada M Tsuneyoshi M. c-erbB-2 and c-Met expression relates to cholangiocarcinogenesis and progression of intrahepatic cholangiocarcinoma Histopathology 2002 40 269 78
24. Radaeva S Ferreira-Gonzalez A Sirica AE. Overexpression of C-NEU and C-MET during rat liver cholangiocarcinogenesis: a link between biliary intestinal metaplasia and mucin-producing cholangiocarcinoma Hepatology 1999 29 1453 62
25. Wu T Han C Lunz JG III. Michalopoulos G Shelhamer JH Demetris AJ. Involvement of 85-kd cytosolic phospholipase A(2) and cyclooxygenase-2 in the proliferation of human cholangiocarcinoma cells Hepatology 2002 36 363 73
26. Ahrendt SA Rashid A Chow JT Eisenberger CF Pitt HA Sidransky D. p53 overexpression and K-ras gene mutations in primary sclerosing cholangitis-associated biliary tract cancer J Hepatobiliary Pancreat Surg 2000 7 426 31
27. Okabayashi T Yamamoto J Kosuge T et al. A new staging system for mass-forming intrahepatic cholangiocarcinoma: analysis of preoperative and postoperative variables Cancer 2001 92 2374 83
28. Neuhaus P Jonas S Settmacher U et al. Surgical management of proximal bile duct cancer: extended right lobe resection increases resectability and radicality Langenbecks Arch Surg 2003 388 194 200
29. Jarnagin WR Fong Y DeMatteo RP et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma Ann Surg 2001 234 507 17 discussion 517 9
30. Abdalla EK Barnett CC Doherty D Curley SA Vauthey JN. Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization Arch Surg 2002 137 675 80 discussion 680 1
31. Farges O Belghiti J Kianmanesh R et al. Portal vein embolization before right hepatectomy: prospective clinical trial Ann Surg 2003 237 208 17
32. Heron DE Stein DE Eschelman DJ et al. Cholangiocarcinoma: the impact of tumor location and treatment strategy on outcome Am J Clin Oncol 2003 26 422 8
33. Serafini FM Sachs D Bloomston M et al. Location, not staging, of cholangiocarcinoma determines the role for adjuvant chemoradiation therapy Am Surg 2001 67 839 43 discussion 843 4
34. Yoshida T Matsumoto T Sasaki A Morii Y Aramaki M Kitano S. Prognostic factors after pancreatoduodenectomy with extended lymphadenectomy for distal bile duct cancer Arch Surg 2002 137 69 73
35. Heimbach JK Gores GJ Haddock MG et al. Liver transplantation for unresectable perihilar cholangiocarcinoma Semin Liver Dis 2004 24 201 7
36. Pitt HA Nakeeb A Abrams RA et al. Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival Ann Surg 1995 221 788 97 discussion 797 8
37. Cherqui D Tantawi B Alon R et al. Intrahepatic cholangiocarcinoma. Results of aggressive surgical management Arch Surg 1995 130 1073 8
38. Kelley ST Bloomston M Serafini F et al. Cholangiocarcinoma: advocate an aggressive operative approach with adjuvant chemotherapy Am Surg 2004 70 743 8 discussion 748 9
39. Goldstein RM Stone M Tillery GW et al. Is liver transplantation indicated for cholangiocarcinoma Am J Surg 1993 166 768 71 discussion 771 2
40. De Palma GD Galloro G Siciliano S Iovino P Catanzano C. Unilateral versus bilateral endoscopic hepatic duct drainage in patients with malignant hilar biliary obstruction: results of a prospective, randomized, and controlled study Gastrointest Endosc 2001 53 547 53
41. Davids PH Groen AK Rauws EA Tytgat GN Huibregtse K. Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction Lancet 1992 340 1488 92
42. Ortner MA Liebetruth J Schreiber S et al. Photodynamic therapy of nonresectable cholangiocarcinoma Gastroenterology 1998 114 536 42
43. Berr F Wiedmann M Tannapfel A et al. Photodynamic therapy for advanced bile duct cancer: evidence for improved palliation and extended survival Hepatology 2000 31 291 8
44. Harewood GC Baron TH Rumalla A et al. Pilot study to assess patient outcomes following endoscopic application of photodynamic therapy for advanced cholangiocarcinoma J Gastroenterol Hepatol 2005 20 415 20
45. Zgodzinski W Espat NJ. Radiofrequency ablation for incidentally identified primary intrahepatic cholangiocarcinoma World J Gastroenterol 2005 11 5239 40
46. Slakey DP. Radiofrequency ablation of recurrent cholangiocarcinoma Am Surg 2002 68 395 7
47. Chiou YY Hwang JI Chou YH Wang HK Chiang JH Chang CY. Percutaneous ultrasound-guided radiofrequency ablation of intrahepatic cholangiocarcinoma Kaohsiung J Med Sci 2005 21 304 9
48. Burger I Hong K Schulick R et al. Transcatheter arterial chemoembolization in unresectable cholangiocarcinoma: initial experience in a single institution J Vasc Interv Radiol 2005 16 353 61
49. Waggershauser T Herrmann K Schalhorn A Reiser M. Percutaneous implantation of port-catheter systems for intraarterial chemotherapy of the liver Radiologe 1999 39 772 6
50. Tanaka N Yamakado K Nakatsuka A Fujii A Matsumura K Takeda K. Arterial chemoinfusion therapy through an implanted port system for patients with unresectable intrahepatic cholangiocarcinoma - initial experience Eur J Radiol 2002 41 42 8
51. Chen Y Wang XL Yan ZP et al. HDR-192Ir intraluminal brachytherapy in treatment of malignant obstructive jaundice World J Gastroenterol 2004 10 3506 10
52. Dingle BH Rumble RB Brouwers MC. The role of gemcitabine in the treatment of cholangiocarcinoma and gallbladder cancer: a systematic review Can J Gastroenterol 2005 19 711 6
53. Jan YY Yeh CN Yeh TS Hwang TL Chen MF. Clinicopathological factors predicting long-term overall survival after hepatectomy for peripheral cholangiocarcinoma World J Surg 2005 29 894 8
54. Yeh CN Jan YY Yeh TS Hwang TL Chen MF. Hepatic resection of the intraductal papillary type of peripheral cholangiocarcinoma Ann Surg Oncol 2004 11 606 11
55. Nakagohri T Asano T Kinoshita H et al. Aggressive surgical resection for hilar-invasive and peripheral intrahepatic cholangiocarcinoma World J Surg 2003 27 289 93
56. Han S Wang H Xu L. Diagnosis and surgical treatment of peripheral intrahepatic cholangiocarcinoma Chin J Surg 2001 39 590 2
57. El Rassi ZE Partensky C Scoazec JY Henry L Lombard-Bohas C Maddern G. Peripheral cholangiocarcinoma: presentation, diagnosis, pathology and management Eur J Surg Oncol 1999 25 375 80
58. Isaji S Kawarada Y Taoka H Tabata M Suzuki H Yokoi H. Clinicopathological features and outcome of hepatic resection for intrahepatic cholangiocarcinoma in Japan J Hepatobiliary Pancreat Surg 1999 6 108 16
59. Harrison LE Fong Y Klimstra DS Zee SY Blumgart LH. Surgical treatment of 32 patients with peripheral intrahepatic cholangiocarcinoma Br J Surg 1998 85 1068 70
60. Madariaga JR Iwatsuki S Todo S Lee RG Irish W Starzl TE. Liver resection for hilar and peripheral cholangiocarcinomas: a study of 62 cases Ann Surg 1998 227 70 9
61. Casavilla FA Marsh JW Iwatsuki S et al. Hepatic resection and transplantation for peripheral cholangiocarcinoma J Am Coll Surg 1997 185 429 36
62. Berdah SV Delpero JR Garcia S. A western surgical experience of peripheral cholangiocarcinoma Br J Surg 1996 83 1517 21
63. Silva MA Tekin K Aytekin F Bramhall SR Buckels JA Mirza DF. Surgery for hilar cholangiocarcinoma; a 10 year experience of a tertiary referral centre in the UK Eur J Surg Oncol 2005 31 533 9
64. Jarnagin WR Bowne W Klimstra DS et al. Papillary phenotype confers improved survival after resection of hilar cholangiocarcinoma Ann Surg 2005 241 703 12 discussion 712 4
65. Otto G Romaneehsen B Hoppe-Lotichius M Bittinger F. Hilar cholangiocarcinoma: resectability and radicality after routine diagnostic imaging J Hepatobiliary Pancreat Surg 2004 11 310 8
66. Kondo S Hirano S Ambo Y et al. Forty consecutive resections of hilar cholangiocarcinoma with no postoperative mortality and no positive ductal margins: results of a prospective study Ann Surg 2004 240 95 101
67. Rea DJ Munoz-Juarez M Farnell MB et al. Major hepatic resection for hilar cholangiocarcinoma: analysis of 46 patients Arch Surg 2004 139 514 23 discussion 523 5
68. Ebata T Nagino M Kamiya J Uesaka K Nagasaka T Nimura Y. Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases Ann Surg 2003 238 720 7
69. Capussotti L Muratore A Polastri R Ferrero A Massucco P. Liver resection for hilar cholangiocarcinoma: in-hospital mortality and long term survival J Am Coll Surg 2002 195 641 7
70. Munoz L Roayaie S Maman D et al. Hilar cholangiocarcinoma involving the portal vein bifurcation: long-term results after resection J Hepatobiliary Pancreat Surg 2002 9 237 41
71. Nagino M Nimura Y. Combined portal vein and liver resection for biliary cancer Nippon Geka Gakkai Zasshi 2001 102 815 9
72. Bathe OF Pacheco JT Ossi PB et al. Management of hilar bile duct carcinoma Hepatogastroenterology 2001 48 1289 94
73. Figueras J Llado L Valls C et al. Changing strategies in diagnosis and management of hilar cholangiocarcinoma Liver Transpl 2000 6 786 94
74. Havlik R Sbisa E Tullo A et al. Results of resection for hilar cholangiocarcinoma with analysis of prognostic factors Hepatogastroenterology 2000 47 927 31
75. Tabata M Kawarada Y Yokoi H Higashiguchi T Isaji S. Surgical treatment for hilar cholangiocarcinoma J Hepatobiliary Pancreat Surg 2000 7 148 54
76. Nimura Y Kamiya J Kondo S et al. Aggressive preoperative management and extended surgery for hilar cholangiocarcinoma: Nagoya experience J Hepatobiliary Pancreat Surg 2000 7 155 62
77. Gazzaniga GM Filauro M Bagarolo C Mori L. Surgery for hilar cholangiocarcinoma: an Italian experience J Hepatobiliary Pancreat Surg 2000 7 122 7
78. Tsao JI Nimura Y Kamiya J et al. Management of hilar cholangiocarcinoma: comparison of an American and a Japanese experience Ann Surg 2000 232 166 74